Further studies on larger populations are required to confirm the incrimination of OPTN in POAG, to discriminate OPTN mutations causing POAG from those acting only as risk factors, and to ascertain the rate of loss-of-function OPTN variants in different populations. This evidence concerns the gene OPTN and open-angle glaucoma.